Gene · 91
Papers1,784
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,784
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ARID1A loss derepresses a group of human endogenous retrovirus-H loci to modulate BRD4-dependent transcription. | Nat Commun | 2022 | 35715442 | PubTator, text mining | PubMed |
| GDF-11 promotes human trophoblast cell invasion by increasing ID2-mediated MMP2 expression. | Cell Commun Signal | 2022 | 35705978 | PubTator, text mining | PubMed |
| Regulatory Role and Potential Importance of GDF-8 in Ovarian Reproductive Activity. | Front Endocrinol (Lausanne) | 2022 | 35692411 | PubTator, text mining | PubMed |
| Novel targets in rectal cancer by considering lncRNA-miRNA-mRNA network in response to Lactobacillus acidophilus consumption: a randomized clinical trial. | Sci Rep | 2022 | 35654932 | PubTator, text mining | PubMed |
| Hypoxia-induced inhibin promotes tumor growth and vascular permeability in ovarian cancers. | Commun Biol | 2022 | 35654828 | PubTator, text mining | PubMed |
| Cell-Based HIF1α Gene Therapy Reduces Myocardial Scar and Enhances Angiopoietic Proteome, Transcriptomic and miRNA Expression in Experimental Chronic Left Ventricular Dysfunction. | Front Bioeng Biotechnol | 2022 | 35646882 | PubTator, text mining | PubMed |
| Bone morphogenetic protein signaling regulation of AMPK and PI3K in lung cancer cells and C. elegans. | Cell Biosci | 2022 | 35641992 | PubTator, text mining | PubMed |
| Effects of Multi-Omics Characteristics on Identification of Driver Genes Using Machine Learning Algorithms. | Genes (Basel) | 2022 | 35627101 | PubTator, text mining | PubMed |
| Identification of Immune-Related Genes Concurrently Involved in Critical Illnesses Across Different Etiologies: A Data-Driven Analysis. | Front Immunol | 2022 | 35615364 | PubTator, text mining | PubMed |
| Bioinformatics network analyses of growth differentiation factor 11. | Open Life Sci | 2022 | 35582621 | PubTator, text mining | PubMed |
| Activin-A impairs CD8 T cell-mediated immunity and immune checkpoint therapy response in melanoma. | J Immunother Cancer | 2022 | 35580932 | PubTator, text mining | PubMed |
Prohaptoglobin inhibits the transforming growth factor-β-induced epithelial-to-mesenchymal transition in vitro by increasing Smad1/5 activation and suppressing the Smad2/3 signaling pathway in SK-Hep1 liver cancer cells. | PLoS One | 2022 | 35580109 | PubTator, text mining | PubMed |
| Optimization of production and characterization of a recombinant soluble human Cripto-1 protein inhibiting self-renewal of cancer stem cells. | J Cell Biochem | 2022 | 35578735 | PubTator, text mining | PubMed |
| Genome-Wide Identification of Associations of Circulating Molecules With Spontaneous Coronary Artery Dissection and Aortic Aneurysm and Dissection. | Front Cardiovasc Med | 2022 | 35571188 | PubTator, text mining | PubMed |
| Framework of Intrinsic Immune Landscape of Dormant Prostate Cancer. | Cells | 2022 | 35563856 | PubTator, text mining | PubMed |
| Stimulation of the atypical chemokine receptor 3 (ACKR3) by a small-molecule agonist attenuates fibrosis in a preclinical liver but not lung injury model. | Cell Mol Life Sci | 2022 | 35562519 | PubTator, text mining | PubMed |
| The role of miRNA-210 in pre-eclampsia development. | Ann Med | 2022 | 35543206 | PubTator, text mining | PubMed |
| EZH2 engages TGFβ signaling to promote breast cancer bone metastasis via integrin β1-FAK activation. | Nat Commun | 2022 | 35538070 | PubTator, text mining | PubMed |
| The Impact of lncRNA on Diabetic Kidney Disease: Systematic Review and In Silico Analyses. | Comput Intell Neurosci | 2022 | 35528328 | PubTator, text mining | PubMed |
| AR cooperates with SMAD4 to maintain skeletal muscle homeostasis. | Acta Neuropathol | 2022 | 35522298 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/91/papers?page=16